Assessing response to biological therapies in severe asthma

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to evaluate how to achieve clinical remission in severe asthma through multidimensional assessments.
Assessment of symptom control
Evaluation of lung function stability
Analysis of OCS (oral corticosteroid) elimination
Identification of specific asthma phenotypes
Discussion of standardized criteria for remission
Achieving remission requires more than just symptom control
Future therapies may focus on disease modification
Early biologic intervention could enhance patient outcomes
Identifying specific phenotypes allows for personalized treatment
Establishing standardized criteria for remission is essential for future research.

Answers are grounded in this paper and cite their sources.

This analysis examines clinical remission in severe asthma, indicating the need for tailored therapies and ongoing research challenges.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Maglio et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share